SK pharmteco
Felix Perez is a Senior Process Scientist at SK pharmteco since January 2024, with extensive experience in fine chemicals manufacturing. Prior to this, Felix held various roles at AMPAC Fine Chemicals from October 2016, including Process Scientist II, contributing to synthetic route scouting and management of complex processes involving potent APIs and advanced chemical reactions. Academic roles include serving as a Postdoctoral Teaching Associate at Southwestern University, mentoring undergraduate researchers, and conducting NIH-funded research at The University of Texas at Austin, focusing on metal-catalyzed syntheses and natural product synthesis. Felix earned a PhD in Organic Chemistry from UCLA, where research involved the Diels-Alder reaction's application to morphine synthesis and other advanced organic transformations. Additional experience includes internships at Amgen and Pfizer, contributing to significant advancements in medicinal chemistry processes. Felix holds a Bachelor's Degree in Chemistry from California State University, Fresno.
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.